D&D Pharmatech
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.asserted
- Valid from
- 2026-06-16
- Valid until
- still holds
- Published
- 2026-06-17
- Recorded by AsOf
- 2026-11-19
- Checked
- 2026-11-19 · its source page states the value and the date, as read by an AI model
- Confidence
- 0.70
Sources
“LG AI Research signed a definitive agreement with D&D Pharmatech on June 16 at the LG Twin Towers in Yeouido, Seoul, to jointly develop next-generation peptide therapeutics.”— what the page says, read 2026-11-19
Cite this claim
Plain text
AsOf. "LG AI Research partnership: D&D Pharmatech", as of 2026-06-16. Claim clm_D8C6FC3022EE, https://asof.is/claim/clm_D8C6FC3022EE, accessed 2026-11-20. Source: https://www.lgresearch.ai/news/view?seq=657.
APA
AsOf. (2026). LG AI Research partnership: D&D Pharmatech (as of 2026-06-16) [Record clm_D8C6FC3022EE]. Retrieved November 20, 2026, from https://asof.is/claim/clm_D8C6FC3022EE (source: https://www.lgresearch.ai/news/view?seq=657)
BibTeX
@misc{asof_clm_D8C6FC3022EE,
author = {AsOf},
title = {LG AI Research partnership: D\&D Pharmatech},
year = {2026},
howpublished = {\url{https://asof.is/claim/clm_D8C6FC3022EE}},
note = {Claim clm\_D8C6FC3022EE, as of 2026-06-16; source: https://www.lgresearch.ai/news/view?seq=657},
urldate = {2026-11-20}
}On the record
/claim/clm_D8C6FC3022EE.md/v1/claims/clm_D8C6FC3022EEsubmit a correction